Michael Sherman - RadNet Independent Director
| RDNT Stock | USD 47.61 0.19 0.40% |
Director
Dr. Michael L. Sherman, M.D. is an Independent Director of RadNet, Inc. Dr. Sherman is a director of Radiologix between 1997 and November 2006, until its acquisition by the Company. He founded and served as President of Advanced Radiology, P.A., a 90person radiology practice located in Baltimore, Maryland, from its inception in 1995 to 2001, and subsequently as its board chairman and a consultant until his retirement from active clinical practice in 2005. In addition, Dr. Sherman was a director of MedStar Health, a tenhospital system in the BaltimoreWashington, D.C. area from 1998 until 2006 and served as a director of Medstars captive insurance company until 2011. Dr. Sherman has trained as a mediator and serves as president of Medical Mediation, LLC through which he has mediated professional liability and business cases. He was a director of HX Technologies, a healthcare IT private company, from 2006 until its sale in 2010 since 2007.
| Age | 74 |
| Tenure | 17 years |
| Professional Marks | Ph.D |
| Address | 1510 Cotner Avenue, Los Angeles, CA, United States, 90025 |
| Phone | 310 478 7808 |
| Web | https://www.radnet.com |
RadNet Management Efficiency
The company has return on total asset (ROA) of 0.0237 % which means that it generated a profit of $0.0237 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0465 %, meaning that it created $0.0465 on every $100 dollars invested by stockholders. RadNet's management efficiency ratios could be used to measure how well RadNet manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to 0 in 2024. Return On Capital Employed is likely to gain to 0.04 in 2024. At this time, RadNet's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 3 B in 2024, whereas Non Current Liabilities Other is likely to drop slightly above 6.4 M in 2024.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Frank Gordon | HealthStream | 55 | |
| Martiny Harris | HealthStream | 59 | |
| Allen Moseley | Streamline Health Solutions | 46 | |
| Michael DAmato | Evolent Health | 66 | |
| David Farner | Evolent Health | 56 | |
| Bridget Duffy | Evolent Health | 60 | |
| John Paglia | Simulations Plus | 48 | |
| Michael Shmerling | HealthStream | 62 | |
| Thaddeus Grasela | Simulations Plus | 61 | |
| William Stead | HealthStream | 69 | |
| Kenan Lucas | Streamline Health Solutions | 33 | |
| Bruce Felt | Evolent Health | 61 | |
| David Ralph | Simulations Plus | 68 | |
| Matthew Hobart | Evolent Health | 47 | |
| Lisa LaVange | Simulations Plus | N/A | |
| Michael Valentine | Streamline Health Solutions | 47 | |
| Linda Rebrovick | HealthStream | 62 | |
| Deborah Tate | HealthStream | 61 | |
| Daniel Weiner | Simulations Plus | 66 | |
| Thompson Dent | HealthStream | 68 | |
| Robert Musslewhite | Evolent Health | 44 | |
Management Performance
| Return On Equity | 0.0465 | ||||
| Return On Asset | 0.0237 |
RadNet Inc Leadership Team
Elected by the shareholders, the RadNet's board of directors comprises two types of representatives: RadNet inside directors who are chosen from within the company, and outside directors, selected externally and held independent of RadNet. The board's role is to monitor RadNet's management team and ensure that shareholders' interests are well served. RadNet's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, RadNet's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mital Patel, Executive Vice President - Finance | ||
| Christine Gordon, Senior Director | ||
| Michael Sherman, Independent Director | ||
| Ranjan Jayanathan, Chief VP | ||
| Norman Hames, COO of Western Operations, Executive VP, Secretary and Director | ||
| Michael Murdock, Executive Vice President Chief Development Officer | ||
| John Crues, Vice President Medical Director, Director | ||
| Todd Skulte, Executive Vice President - Hospital Based Operations | ||
| Lawrence Levitt, Independent Director | ||
| Howard MD, President Chairman | ||
| Stephen Forthuber, COO of Eastern Operations and Executive VP | ||
| Ruth VilligerWilson, HR Director | ||
| Gregory MD, Chief VP | ||
| BSRT MPH, VP Affairs | ||
| David Swartz, Lead Independent Director | ||
| Jeffrey Linden, Executive VP and General Counsel | ||
| Howard Berger, Chairman of the Board and Presidentident, CEO | ||
| David Katz, Chief VP | ||
| Mark Stolper, CFO and Executive VP | ||
| Derek Bomar, Senior Vice President Director of Materials and Asset Management | ||
| Marvin Cadwell, Independent Director |
RadNet Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is RadNet a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0465 | ||||
| Return On Asset | 0.0237 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 4.59 B | ||||
| Shares Outstanding | 73.71 M | ||||
| Shares Owned By Insiders | 11.45 % | ||||
| Shares Owned By Institutions | 75.19 % | ||||
| Number Of Shares Shorted | 2.96 M | ||||
| Price To Earning | 55.56 X |
Currently Active Assets on Macroaxis
When determining whether RadNet Inc is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if RadNet Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Radnet Inc Stock. Highlighted below are key reports to facilitate an investment decision about Radnet Inc Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RadNet Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for RadNet Stock analysis
When running RadNet's price analysis, check to measure RadNet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RadNet is operating at the current time. Most of RadNet's value examination focuses on studying past and present price action to predict the probability of RadNet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RadNet's price. Additionally, you may evaluate how the addition of RadNet to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is RadNet's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of RadNet. If investors know RadNet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about RadNet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 24 | Earnings Share 0.05 | Revenue Per Share 25.427 | Quarterly Revenue Growth 0.095 | Return On Assets 0.0237 |
The market value of RadNet Inc is measured differently than its book value, which is the value of RadNet that is recorded on the company's balance sheet. Investors also form their own opinion of RadNet's value that differs from its market value or its book value, called intrinsic value, which is RadNet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because RadNet's market value can be influenced by many factors that don't directly affect RadNet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between RadNet's value and its price as these two are different measures arrived at by different means. Investors typically determine if RadNet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, RadNet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.